Lif finds positives in Danish finance bill

The Danish Pharmaceutical Industry Association, Lif, has given its verdict on the government  financial bill setting out new priorities in health in 2025.

Lif has called the bill ‘one of the more subdued’ in its support for healthcare in general, but welcomed positive aspects such as money being found to strengthen the fight against antibiotic resistance, and the choice to continue the seasonal vaccination program for the elderly at the same time.

Ida Sofie Jensen, Lif’s chief executive, said: ”We are reading the financial bill in the light of the agreements that have already been made in the area of ​​health, ie about Cancer Plan V and the Psychiatry Plan, as well as in relation to the strategy for personalized medicine and advanced therapies that the government has announced later this year. Therefore, it is of course positive overall that the government will raise the financial framework in the health area by 400 million Danish kroner ($59.4 million), annually.”